Naturally occurring thymocytotoxic autoantibody (NTA) was detected by cytotoxic test in the sera of very young New Zealand Black mice (within 1 month after birth); the incidence was 100% at 3 months of age. Some mice from other strains also had NTA, but at an older age and with lower incidence and antibody titer.
strains of mice tested. Whereas only thymocytes were highly sensitive to NTA, the reactive antigen was demonstrated by absorption test in the thymus, lymph node, spleen, and brain of adult mice. It could be demonstrated only in the thymus of newborn mice.
The distribution of NTA-reactive antigen suggests the presence of an antigen distinct from any so far described on the cell surface of mouse thymocytes. Gel filtration of NZB mouse serum suggests that NTA is an IgM. Mouse thymocytes sensitized with NTA in vitro became highly susceptible to phagocytosis by syngeneic macrophages.
The New Zealand Black (NZB) strain of mice is immunologically characterized by the spontaneous production of antierythrocyte autoantibodies beginning at about 4 months of age, followed by the development of autoimmune hemolytic anemia (1) . Lupus erythematosus cell-inducing (2) , antinuclear (3), anti-DNA (4), and anti-RNA (5) antibodies also occur in NZB mice but are more prevalent in (NZB X NZW) F, hybrid mice. NZB mice carry G (Gross)-type murine leukemia-like virus, apparently throughout life, but break tolerance to G (Gross) antigens and produce circulating free antibodies to G cell-surface (6) and viral-envelope (7) antigens in later life. In addition, thymic lesions (8, 9) and a depletion of recirculating, long-lived small lymphocytes (10) months. The age prevalence of positive tests for NTA was the same in male and female mice. Fig. 1 shows the NTA titration ini representative sera from mice at 3 and 7 months of age.
The NTA titer increased with age.
47% of (NZW X NZB) F1 mice were positive for NTA at 5-7 months of age, and 100% were positive after 12 months of age. Several other mouse strains, NZW, C57BL/6J, AKR/J, BALB/cJ, and 129/J were positive for NTA after 5 months of age, but the prevalence and the titers of NTA were much lower than in NZB mice at corresponding ages.
Distribution of NTA-reactive antigen
Thymocytes of C57BL/6J mice were used as test cells in the preceding experiments. However, NTA was found to be cvtotoxic also for thymocytes from all strains of mice tested: NZB, C57BL/6J, AKR/J, RF/J, SJL/J, DBA/2J, SWR/J, A/J, BALB/cJ, C58/J, C3H/HeJ, and C3HeB/FeJ. The thymocytes from these strains of mice displayed similar cytotoxic sensitivity to the NTA-positive NZB mouse serum pool. Absorption tests showed that the thymocytes from each of these strains of mice absorbed the cytotoxicity of the NTApositive NZB mouse serum pool for C57BL/6J thymocytes. Tests with cells of C57BL/6J mice indicated that the cytotoxicity of the NZB mouse serum was strong for thymocytes, very weak for lymph node cells, spleen cells, and blood leukocytes, and negative or questionable for bone marrow cells and peritoneal cells (Fig. 2) . As shown by absorption tests with cells or tissue homogenates prepared from adult C57BL/ 6J mice, the thymus, lymph node, spleen, and brain absorbed the cytotoxic antibody (Table 2) . Similar results were obtained with corresponding cells and homogenates prepared from adult NZB, BALB/cJ, and AKR/J mice, including NZB mice possessing NTA. In contrast, brain homogenates and spleen cells prepared from newborn NZB mice did not absorb NTA, whereas the thymocytes were strongly positive; lymph nodes were not available in sufficient amounts for testing. In addition to these normal tissues of mice, malignant lymphoid cells originating in the thymus also had NTAreactive antigen: transplantable thymoma cells of NZB mice strongly absorbed NTA.
Properties of NTA Fractionation of NZB mouse serum pool on Sephadex G-200 showed that NTA occurred only in the first peak (excluded fractions), in contrast to the other natural antibodies which appeared in the second peak, e.g., antierythrocyte autoantibody, antinuclear antibody, and G (Gross) natural antibody. Thus NTA is probably an IgMI immunoglobulin. NTA is stable for 30 min at 560C, but rather labile when held for 15 or 30 min at 60°C. Cryoglobulin separated from an NTA-positive NZB serum pool did not react with mouse thymocytes.
In order to explore the immunobiological activity of NTA further, we studied the opsonic or immunophagocytic activity of NTA in vitro. As shown in Table 3 and Fig. 3 natural antibodies in NZB mice and is apparently the earliest natural antibody produced in these mice. NTA is probably an IgM immunoglobulin and shows optimum reactivity with mouse thymocytes at 40C, but is also reactive at 370C. NTA of NZB mice is cytotoxic for syngeneic thymocytes as well as for the thymocytes of all other mouse strains tested. NTA is an autoantibody.
The occurrence of a somewhat similar NTA with the characteristics of IgM in the sera of mice of the 129 strain was described by Schlesinger (11) . Our studies indicated that 3 of 16 mice of the 129 strain at 6 months of age had NTA as determined by the method used in the present work. The prevalence of NTA was almost the same as found in C57BL/6J and AKR/J mice at comparable ages. Additional preliminary studies (unpublished) Analysis based on the absorption test indicated that NTA-reactive antigen was distributed in the thymus, spleen, lymph node, and brain of adult mice but only in the thymus of newborn mice (Table 2) . However, only thymocytes were highly sensitive to the cytotoxic effect of NTA. Lymph node cells, spleen cells, and blood leukocytes were also sensitive but very weakly so. It is not known whether NTA reacts only with thymocytes (thymic lymphocytes) and thymus-derived lymphocytes in peripheral organs or with lymphocytes of other origin as well. If all the lymphocytes in peripheral organs or in blood had a low concentration of the reactive antigen on the cell surface, the lymphocytes could absorb NTA but without demonstrable sensitivity to its cytotoxic effect.
The observed characteristics of NTA-reactive antigen are very similar to the 0 alloantigen in mice (16) . The 0 alloantigen system is also distributed in the thymus, spleen, lymph node, and brain of adult mice but only in the thymus of newborn mice and comprises at least two separate antigenic components: 0-AKR in AKR and RF mice and 0-C3H in C3H mice and in mouse strains other than AKR and RF. The NTA-reactive antigen described here is distributed in mice of all strains studied, including the AKR and C3H. The thymocytes from all mouse strains, whether possessing either 0-AKR or 0-C3H, displayed almost the same sensitivity to the cytotoxic action of the NTA-positive NZB mouse serum pool; this excludes the presence of 0 alloantibody in the NZB mouse serum. The broad distribution of NTA-reactive antigen in various strains of mice suggests the existence on the cell surface of thymocytes of a newly discovered antigen, distinct from other known antigens on mouse thymocytes (17) .
The biological and pathological significance of NTA is unknown at present but may prove to be of fundamental importance. Our experiments indicated that NTA promoted the opsonization, or the immune phagocytosis, of mouse thymocytes in vitro. If NTA were to have a regulatory role on thymocytes and thymus-derived lymphocytes in vivo, NTA could influence many of the cellular events involved in the induction of cellular and humoral immunity and the development of self-tolerance. Some normal mice of nonautoimmune strains had NTA, but in later life and in low titer. NZB mice, an autoimmune strain, produced NTA very early in life and inl high titer. Young NZB mice are known to show hyperactivity of antibody production to some antigens and an impairment of the induction and maintenance of immunological tolerance (18) ; older NZB mice have an impairment of cellular immunity (19) and a depletion of recirculating, longlived small lymphocytes (10) . In the field of human medicine, lymphocytotoxic antibodies have been detected in high titer in the serum of patients with the autoimmune diseases systemic lupus erythematosus and rheumatoid arthritis, and in low titer in patients with the viral diseases infectious mononucleosis, rubella, and rubeola (20) , and in the serum of patients with Hodgkin's disease (21) . It is noteworthy that NZB mice carry murine leukemia-like virus particles, apparently throughout life (6) ; but the relation of this persisting viral infection to the production of NTA is unknown at present.
